XopD (Xanthomonas outer protein D), a type III secreted effector from Xanthomonas campestris pv. vesicatoria, is a desumoylating enzyme with strict specificity for its plant small ubiquitin-like modifier (SUMO) substrates. Based on SUMO sequence alignments and peptidase assays with various plant, yeast, and mammalian SUMOs, we identified residues in SUMO that contribute to XopD/SUMO recognition. Further predictions regarding the enzyme/substrate specificity were made by solving the XopD crystal structure. By incorporating structural information with sequence alignments and enzyme assays, we were able to elucidate determinants of the rigid SUMO specificity exhibited by the Xanthomonas virulence factor XopD.
XopD (Xanthomonas outer protein D), a type III secreted effector from Xanthomonas campestris pv. vesicatoria, is a desumoylating enzyme with strict specificity for its plant small ubiquitin-like modifier (SUMO) substrates. Based on SUMO sequence alignments and peptidase assays with various plant, yeast, and mammalian SUMOs, we identified residues in SUMO that contribute to XopD/SUMO recognition. Further predictions regarding the enzyme/substrate specificity were made by solving the XopD crystal structure. By incorporating structural information with sequence alignments and enzyme assays, we were able to elucidate determinants of the rigid SUMO specificity exhibited by the Xanthomonas virulence factor XopD.
The small ubiquitin-like modifier (SUMO)
2 is a member of a large family of reversible post-translational modifiers. SUMO is structurally similar to ubiquitin. Like ubiquitin, SUMO utilizes a conjugation machinery (ubiquitin-activating enzyme, ubiquitin carrier protein, and ubiquitin-protein isopeptide ligase) to modify target proteins, but sumoylated proteins are not targeted for degradation by the proteasome (1) . The conjugation machinery catalyzes the formation of a covalent isopeptide bond between the C-terminal glycine residue of SUMO and the ⑀-amino group of a lysine residue in the target protein. The removal of SUMO moieties from conjugated proteins by isopeptidases regenerates pools of processed SUMOs and unmodified target proteins.
Yeast Ulp1 is the founding member of a growing family of these isopeptidases or desumoylating enzymes. Ubiquitin-like protein proteases (ULPs) constitute peptidase family C48 and include animals, plants, fungi, bacteria, and viruses (2) . Besides being isopeptidases that remove SUMO from SUMO-conjugated target proteins, these enzymes are also proteases that cleave full-length SUMO to produce the mature form of SUMO (exposing its C-terminal Gly-Gly motif) (3) .
Seven ULPs have been identified in humans. They are referred to as SENP1, -2, -3, -5, -6, -7, and -8 (4). All sentrinspecific proteases (SENPs) share the conserved C-terminal peptidase domain with yeast Ulp1, yet they differ in size, N-terminal regulatory domain sequence, substrate preference, and subcellular localization (4, 5) . SENP1 and SENP2 have been shown to process mammalian SUMO-1, -2, and -3 conjugates (6, 7) . SENP3 is localized to the nucleolus during interphase and is known to process mammalian SUMO-2 and SUMO-3 (8) . SENP5 exhibits isopeptidase activity for SUMO-2-and SUMO-3-modified proteins (9) . SENP6 is found in the cytoplasm and is considered to be an Ulp2-like enzyme, i.e. it is thought to exhibit mainly peptidase activity as opposed to isopeptidase activity (10) . SENP7 is not characterized in the literature to date. Unlike the other characterized SENPs, SENP8 removes Nedd8 (another ubiquitin-like protein) from target proteins (11) . So far, five ULP1 genes have been identified in Arabidopsis thaliana. They are referred to as ULP1A, -B, -C, and -D, and ESD4, respectively (12, 13) . A. thaliana ESD4 (early in short days 4) was shown to act as a SUMO protease and is potentially involved in regulating time of flowering (13) . Recently, we characterized four ULPs from A. thaliana and showed that these proteases exhibit substrate specificity both for the processing of SUMO and for the cleavage of SUMO conjugates (14) .
Another ULP, XopD (Xanthomonas outer protein D), is expressed as a secreted virulence factor by Xanthomonas campestris pv. vesicatoria (15) . This pathogen is the causative agent of bacterial spot disease in tomato and pepper plants (16) . Upon contact, Xanthomonas employs an hrp Ϫ (hypersensitive response and pathogenicity) type 3 secretion system to inject effector proteins into host plant cells (17, 18) . There are 20 -25 different proteins that make up a typical type 3 secretion system apparatus, which forms a syringe-like structure projecting across the inner bacterial membrane, the peptidoglycan layer, the outer bacterial membrane, and the host cell wall and plasma * This work was supported in part by NIAID Grant AI056404 from the National membrane to reach the host cell cytoplasm (18, 19) . The effector proteins are transported through this syringe-like channel in an unfolded state to reach the host cell interior (18) , where they interact with specific targets to cause plant cell death (17) . In planta, XopD exhibits an isopeptidase activity that reduces the amount of SUMO protein conjugates (15) . In vitro, XopD exhibits peptidase and isopeptidase activities (15) . XopD appears to be plant-specific as evidenced by the fact that, in vitro, it is able to cleave and activate tomato SUMO (T-SUMO), but not mammalian SUMO (M-SUMO). Likewise, XopD can process plant sumoylated proteins, but not mammalian sumoylated proteins (15) . The activity of XopD is inhibited by mutation of the catalytic cysteine to alanine or serine or by treatment with the chemical inhibitors N-ethylmaleimide and iodoacetamide (15) . AvrXv4, another enzyme from Xanthomonas, was also shown to desumoylate in planta (20) . Because bacteria do not encode either ubiquitin or SUMO signaling machineries, Xanthomonas appears to have usurped the activity of eukaryotic ULPs to aid in pathogenesis by disrupting host defense signaling in the infected plant cell (15, 21, 22) .
Unlike yeast Ulp1, which is promiscuous in its choice of SUMO substrate, XopD demonstrates a rigid specificity (15) . By comparing the sequences of several SUMOs from plants, human, and yeast, one can predict which residues in SUMO might dictate specificity. To gain further insight into the SUMO specificity of XopD, we determined the crystal structures of the catalytic core of XopD and the inactive C470A mutant. On the basis of the structural comparison of XopD with yeast Ulp1 and the analysis of the region surrounding the structurally conserved His-Asp-Cys catalytic triad, we identified residues that we believed to be responsible for the differing specificity of the two enzymes. On the basis of this information, we mutated yeast SUMO (Smt3), creating a substrate that could be cleaved by XopD, and similarly mutated T-SUMO, creating a substrate that could no longer be cleaved by XopD. Thus, using structural, enzymatic and bioinformatic analyses, we were able to identify the residues that dictate the specificity of the plant virulence factor XopD for its eukaryotic substrate plant SUMO.
EXPERIMENTAL PROCEDURES
Cloning and Construction of Plasmids-XopD, T-SUMO, yeast ⌬Ulp1 (Ulp1-(403-621)), and hemagglutinin (HA)-tagged Ran GTPase-activating protein (RanGAP) were prepared as described by Hotson et al. (15) . A. thaliana SUMO (AtSUMO)-1, -2, -3, and -5; Smt3; and M-SUMO-1, -2, and -4 were cloned as described previously (14) .
To generate glutathione S-transferase (GST)-tagged XopD constructs, XopD-(1-545), XopD-(285-545), and XopD-(335-520) were cloned into pGEX-rTEV (see supplemental Table S1 for details) (23) . The N-terminal GST tag can be cleaved with tobacco etch virus protease or thrombin. The GST-tobacco etch virus protease expression vector was a gift from Yuh Min Chook.
Smt3-HA was cloned from Saccharomyces cerevisiae cDNA. T-SUMO-HA was constructed by using pT7-LO (a gift from J. Clemens), and Smt3-HA was constructed by using pET15b (Novagen). These constructs contained an N-terminal HA tag directly following the Gly-Gly motif.
To generate GST-SUMO-Gly-Gly-STOP constructs to be used in in vitro sumoylation assays, AtSUMO-1, -2, and -3; T-SUMO; Smt3; and M-SUMO-1, -2, and -4 were cloned into pGEX-rTEV (23) . These SUMOs were constructed with an N-terminal GST tag and a stop codon after the Gly-Gly motif (see Ref. 14 for details).
To generate His 6 -SUMO-GG-HA constructs to be used in in vitro peptidase assays, AtSUMO-1, -2, and -3; T-SUMO; Smt3; and M-SUMO-1, -2, and -4 were cloned into pET15b, and AtSUMO-5 was cloned into pT7-LOH (gift from J. Clemens). These SUMOs were constructed with an N-terminal His 6 tag, and their C termini contained an HA tag directly following the Gly-Gly motif (see Ref. 14 for details).
The catalytic C470A mutant of XopD and mutants of T-SUMO-HA and Smt3-HA were generated using the QuikChange TM site-directed mutagenesis kit (Stratagene). All mutants were confirmed by DNA sequence analysis (supplemental Table S1 ).
Protein Expression and Purification-GST-tagged XopD constructs, GST-tagged SUMO constructs, and GST-tagged yeast Ulp1 were expressed in Escherichia coli BL21(DE3) cells and purified by GST affinity chromatography (24) . Briefly, cells were grown to A 600 ϭ 0.6 -0.8 in 2ϫ yeast extract and tryptone medium and then induced with 400 M isopropyl ␤-D-thiogalactopyranoside (Roche Applied Science) for 4 h at 30°C. The cells were lysed in phosphate-buffered saline (pH 8), 1% (v/v) Triton X-100 (Fisher), 0.1% (v/v) 2-mercaptoethanol (Bio-Rad), and 1 mM phenylmethylsulfonyl fluoride (Sigma) using a cell disrupter (EmulsiFlex-C5, Avestin Inc.). The lysates were incubated with glutathione-agarose beads, and bound protein was eluted with elution buffer (10 mM reduced glutathione, 50 mM Tris (pH 8), and 150 mM NaCl) as described previously (24) .
In Vitro Peptidase Assays-AtSUMO-1-HA, AtSUMO-2-HA, AtSUMO-3-HA, AtSUMO-5-HA, M-SUMO-1-HA, M-SUMO-2-HA, M-SUMO-4-HA, Smt3-HA (and all Smt3-HA mutants), T-SUMO-HA (and all T-SUMO-HA mutants), and mammalian HA-RanGAP were translated in vitro using the TNT coupled rabbit reticulocyte lysate system (Promega Corp.) with L-[
35 S]methionine (Amersham Biosciences). For each in vitro peptidase assay, 2 l of the 35 Slabeled translation reaction mixture was added to 18 l of 0.5 mg/ml purified XopD for 1 h at 30°C. Elution buffer without glutathione was used as a control. The mixtures were resolved by SDS-PAGE, and the gels were incubated with Amplify fluorographic reagent (Amersham Biosciences) and analyzed by autoradiography.
T-SUMO-His 6 (3.9 nmol) was incubated with submolar amounts of ⌬XopD (0.13, 0.025, and 0.013 nmol) for 0, 1, 5, 10, 30, and 60 min at 30°C. Reactions were terminated by addition of SDS sample buffer, resolved by SDS-PAGE, and analyzed by Coomassie Blue staining.
In Vitro Sumoylation Assays-In vitro sumoylation of 35 Slabeled mammalian HA-RanGAP with GST-AtSUMO-1, GSTAtSUMO-2, GST-AtSUMO-3, GST-AtSUMO-5, GST-T-SUMO, GST-Smt3, GST-M-SUMO-1, GST-M-SUMO-2, and GST-M-SUMO-4 was performed as described previously (14, 25) . In vitro peptidase assays using these sumoylated RanGAP proteins were performed as described above.
Protein Expression and Purification for Crystallization
Experiments-GST-XopD-(335-520) and GST-XopD-(335-520)(C470A) were expressed and purified as described above. After buffer exchange with 50 mM Tris-HCl (pH 8.0), 150 mM NaCl, and 0.1% (v/v) 2-mercaptoethanol by ultrafiltration, the GST moiety was removed by overnight incubation with thrombin (Novagen), followed by glutathione-agarose column purification. The protein was then concentrated using an Amicon ultrafiltration device, and the buffer was exchanged with 20 mM Tris-HCl (pH 7.5), 0.1 M KCl, and 1 mM dithiothreitol (DTT). The concentrated protein was subjected to ion-exchange chromatography (HiTrap Mono Q, Amersham Biosciences) and eluted with a linear gradient of 0.1-1.0 M KCl in 20 mM TrisHCl (pH 7.5) and 1 mM DTT using an Á KTA FPLC system (Amersham Biosciences). At this stage, the protein was either used for initial crystallization screening or further purified for crystal optimization. For this purpose, the protein was subjected to size-exclusion chromatography (HiLoad 16/60 Superdex 75, Amersham Biosciences) in 20 mM Tris-HCl (pH 7.5), 75 mM KCl, and 0.5 mM DTT. The protein was then concentrated to 15 mg/ml for crystallization experiments.
For the production of selenomethionine-labeled protein, the XopD expression vector was transformed into the methionine auxotroph E. coli strain B834 (Novagen). The cells were grown in M9 medium supplemented with 125 mg/liter each adenine, uracil, thymine, and guanosine nucleotide; 2.5 mg/liter thiamin; 4 mg/liter D-biotin; 20 mM glucose; 2 mM magnesium sulfate; and 50 mg/liter L-selenomethionine (Sigma). Selenomethionine-labeled XopD protein was purified as described above. All purified proteins were analyzed by SDS-PAGE and quantified using a modified version (26) of the Lowry procedure.
Protein Crystallization-Wild-type XopD-(335-520) and XopD-(335-520)(C470A) crystals were grown by vapor diffusion in hanging-drop mode at 20°C. Initial screening was performed with the Index crystallization kit (Hampton Research), yielding one hit. Optimized crystallization conditions used drops of 1 l of highly purified XopD (15 mg/ml in 20 mM Tris-HCl (pH 7.5), 75 mM KCl, and 0.5 mM DTT) plus 1 l of reservoir solution (1.4 -1.6 M sodium potassium phosphate (pH 7.5-7.75)) suspended over 0.5 ml of reservoir solution. Crystals typically appeared in 2-7 days. Selenomethionine crystals were obtained under similar conditions that included 5 mM DTT or 10 mM 2-mercaptoethanol. Prior to x-ray diffraction experiments, crystals were cryoprotected by transfer into 1.6 M sodium/potassium phosphate (pH 7.75) supplemented with 15% (v/v) ethylene glycol. Crystals were flash-cooled in liquid propane and then stored in liquid nitrogen.
Data Collection, Structure Determination, and RefinementDiffraction data were collected at 100 K at beamline 19-BM of the Argonne National Laboratory Structural Biology Center at the Advanced Photon Source. Data sets were indexed, integrated, and scaled using the HKL2000 program package (27). XopD-(335-520) crystals exhibited the symmetry of space group P4 1 2 1 2 with unit cell parameters a ϭ b ϭ 92 Å and c ϭ 45 Å, diffracted x-rays to a minimum Bragg spacing (d min ) of 1.8 Å, and contained one molecule in the asymmetric unit (35% solvent). Phases were obtained from a crystal of the selenomethionyl-substituted protein by the single-wavelength anomalous diffraction method using x-rays with an energy near the selenium K-absorption edge. Location of heavy atom sites, phase calculation, and refinement were performed with the program Solve (28) . Density modification was carried out with the program dm (29) . An initial model was constructed automatically using the program ARP/wARP (30) XopD-(335-520)(C470A) crystals were isomorphous to the wild-type crystals; model building and refinement followed a protocol similar to that used for the wild-type structure. The model for the XopD-(335-520)(C470A) protein included all residues except residues 335, 466 -467, and 514 -520 as well as 96 water molecules. Data collection, phasing, and refinement statistics are detailed in Table 1 .
Structure Figures-All figures of XopD and yeast Ulp1 structures were constructed using the MacPyMOL program (34) .
RESULTS AND DISCUSSION

Substrate Specificity of XopD-Previous results showing that
XopD can process T-SUMO, but not M-SUMO-1, led to the hypothesis that XopD exhibits species specificity for its SUMO substrates (15) . Recently, we reported the characterization of several SUMOs and ULPs from A. thaliana and demonstrated that ULP1 shows varying specificity for AtSUMO-1, -2, -3, and -5 as well as for M-SUMO-1, -2, and -4 and yeast SUMO (Smt3) (14) . Sequence comparisons of these SUMOs and T-SUMO revealed a striking similarity (83% sequence identity) among AtSUMO-1, AtSUMO-2, and T-SUMO (supplemental Fig. S1 ). On the basis of this high sequence similarity, we hypothesized that XopD would be able to process both AtSUMO-1 and AtSUMO-2, but not AtSUMO-3 and AtSUMO-5, which show little sequence identity to T-SUMO, Smt3, or M-SUMOs. To explore this possibility, AtSUMO-1, -2, -3, and -5; M-SUMO-1, -2, and -4; and yeast Smt3 were used as substrates for in vitro peptidase assays (Fig. 1A) . All SUMOs used in this peptidase assay were constructed with an HA tag at their C termini directly following their C-terminal Gly-Gly residues (SUMOGly-Gly-HA). Peptidase activity of the enzymes can be detected by their ability to remove the HA tag from the SUMOs, resulting in a cleavage product that migrates faster during SDS-PAGE. Both full-length XopD (XopD-(1-545) ) and only the peptidase domain of XopD (XopD-(285-545)) were tested along with the peptidase domain (amino acids 403-621) of yeast Ulp1 (⌬Ulp1) for their ability to process the panel of SUMO substrates. In all peptidase assays, molar excesses of enzyme to SUMO substrate were used to ensure cleavage of the substrates tested.
XopD preferentially recognized T-SUMO and, as predicted, AtSUMO-1 and AtSUMO-2 (Fig. 1B) .
To demonstrate catalytic processing of substrate by XopD, we performed time course peptidase assays in which recombinant T-SUMO-His 6 was incubated with submolar amounts of recombinant XopD-(285-545) over time. Supplemental Fig. S2 shows that T-SUMO-His 6 was processed to completion within 10 min using 1:10 molar eq of XopD-(285-545) to T-SUMO. Using 1:100 molar eq of enzyme to substrate showed no product formation at 10 min, but close to 100% conversion at 1 h.
To further understand how XopD recognizes its SUMO substrates, the XopD isopeptidase activity for various SUMO substrates was assessed. The isopeptidase activity of XopD was determined using an in vitro sumoylation system with each SUMO expressed as a GST fusion protein and in vitro translated 35 S-RanGAP as the substrate ( Fig. 2A) . In this assay, a fraction of the translated 35 S-RanGAP was modified by the endogenous rabbit reticulocyte lysate (RRL) sumoylation machinery with RRL SUMO. Purified recombinant GSTtagged AtSUMO-1, -2, -3, and -5; M-SUMO-1, -2, and -4; Smt3; and T-SUMO were conjugated to a fraction of the unmodified 35 S-RanGAP and appeared as higher molecular mass bands on an SDS-polyacrylamide gel (Fig. 2B) . Using this in vitro sumoylation system, the substrate specificity of the isopeptidase activity of XopD was consistent with its peptidase activity. XopD could process RanGAP that had been modified by GST-T-SUMO, GST-AtSUMO-1, and GST-AtSUMO-2, but not Ran-GAP that had been modified by GST-AtSUMO-3, GST-At-SUMO-5, the GST-M-SUMOs, or GST-Smt3 (Fig. 2B) . As an internal control, each reaction contained RRL SUMO-Ran-GAP. Yeast ⌬Ulp1, but not XopD, was able to cleave this conjugated RanGAP (Fig. 2B) . Thus, XopD can process T-SUMO, AtSUMO-1, and AtSUMO-2 in peptidase assays as well as in isopeptidase assays. Recently, Colby et al. (35) reported that XopD can process AtSUMO-3 conjugated to yeast proliferating cell nuclear antigen. Although we observed that XopD did not process AtSUMO-3 conjugated to RanGAP, we have shown previously that the regulatory domain of an ULP can change the activity of an enzyme (14) . In this case, it may allow XopD to recognize a SUMO substrate associated with different target proteins.
On the basis of these data and sequence comparisons, we can recognize residues that appear to be important for the specificity of XopD for various SUMOs (Fig. 3) . Using the nomenclature of Schechter and Berger (37) for describing amino acids of substrates and proteases, we observed that residues at the P 5 -P 7 positions (Met-Leu-His) are absolutely conserved in SUMO substrates cleaved by XopD in peptidase and isopeptidase reactions. T-SUMO, AtSUMO-1, and AtSUMO-2 share the same residues, whereas Smt3 and M-SUMO-1, which are both processed only by yeast Ulp1, contain His-Arg-Glu and Tyr-Gln-Glu, respectively. We hypothesized that the charge differences in this region may be important for the specificity by which XopD recognizes its SUMO substrates. Analysis of the co-crystal structure of yeast Ulp1 with Smt3 revealed that the residues at the P 5 -P 7 positions (His 92 , Arg 63 , and Glu 94 ) of Smt3 are in contact with yeast Ulp1 (36) . Because residues at the P 5 -P 7 positions are part of the contact region between yeast Ulp1 and Smt3, it is likely that residues at this position in SUMO play a role in XopD recognition of T-SUMO, AtSUMO-1, and AtSUMO-2.
XopD Structure-The extent of contacts between XopD and T-SUMO, AtSUMO-1, and AtSUMO-2 appears to be very complex and impossible to fully understand based solely on sequence alignments and peptidase assays with various SUMOs. Furthermore, the low sequence identity between XopD and Ulp1 (ϳ19%) made it difficult to use the Ulp1⅐Smt3 complex structure as a basis for future mutagenesis studies in XopD. Thus, structural studies were undertaken to better understand how XopD recognizes its known substrates T-SUMO, AtSUMO-1, and AtSUMO-2. Although we were unable to obtain crystals for an XopD⅐SUMO complex, we were able to solve the crystal structure of XopD alone.
For the XopD structural analysis, we first determined an appropriate protein construct for crystallization experiments with XopD. Initial experiments used the XopD-(285-520) construct, which is similar to the construct of yeast Ulp1 used for structural studies with Smt3 (36) . This construct was purified as an N-terminal GST fusion protein. After removal of the GST tag followed by anion-exchange chromatography, two truncated XopD versions that could not be removed by further puri- fication were observed (supplemental Fig. S3) . A series of new constructs was tested, leading to the well behaved XopD-(335-520) construct, which was ultimately used for crystallization experiments. XopD-(335-520) exhibited identical substrate specificity for all substrates tested with XopD-(285-520) (Figs. 1 and 2 ) (data not shown). We were unable to determine the XopD structure by molecular replacement using the yeast Ulp1 structure as a search model likely because of low sequence similarity between XopD and yeast Ulp1. Therefore, a selenomethionyl-substituted XopD-(335-520) protein crystal was used to obtain phase information via the single-wavelength anomalous diffraction method (Table 1) .
XopD-(335-520) is structurally similar to Ulp1, with both enzymes sharing a central five-stranded ␤-sheet that is sandwiched between six ␣-helices (Figs. 4 and 5) . A superposition of XopD and yeast Ulp1 shows that the central ␤-sheet; helices A, B, and E (nomenclature according to Ref. 36) ; and the catalytic triad are structurally conserved with a root mean square deviation of 1.33 Å for 79 common C-␣ atoms (Fig. 5B) . Major structural differences between XopD and yeast Ulp1 occur in three spatially separated regions, inclusion of which in the superposition increases the root mean square deviation to 1.75 Å for 98 common C-␣ atoms. The first region encompasses helix DЈ, which is close to the presumed SUMObinding site (Figs. 5A and 6 ). Residues from Smt3 are in contact with this portion of Ulp1 and may therefore influence the relative orientation of the Ulp1 backbone. These Ulp1 residues adopt an almost ␣-helical conformation; perhaps this region of Ulp1 is flexible and is able to adopt a helical conformation as seen in free XopD, i.e. in the absence of a substrate. The second region involves a difference in orientation between helices E in XopD and Ulp1 (Figs. 5A and 6 ). These structural elements reside on the outer surface of the proteins and are FIGURE 2. XopD exhibits isopeptidase activity for plant SUMO-modified RanGAP. A, schematic of in vitro SUMO isopeptidase assay. Radiolabeled RanGAP may be sumoylated by either endogenous RRL SUMO or exogenous GST-SUMO. The assay tests the ability of XopD or Ulp1 to cleave the isopeptide bond between RanGAP and RRL SUMO or GST-SUMO. B, XopD shows specificity for the SUMO moiety of sumoylated substrates. 35 S-Labeled mammalian RanGAP was translated in vitro in an RRL. In the RRL, some of the RanGAP was sumoylated by endogenous sumoylation machinery. The in vitro translated product was then used in an in vitro sumoylation assay with purified recombinant GST-T-SUMO, GST-Smt3, GST-M-SUMO-1, GST-M-SUMO-2, GST-M-SUMO-4, GST-AtSUMO-1, GST-AtSUMO-2, GST-AtSUMO-3, or GST-AtSUMO-5 to produce GST-SUMO-modified RanGAP. The SUMO-modified RanGAP was then incubated with buffer or 0.5 mg/ml GST-XopD-(285-545), GST-XopD-(1-545), or GST-Ulp1 for 1 h at 30°C. The samples were resolved by SDS-PAGE and visualized by autoradiography. Shown on the left are autoradiograms of the SDS-PAGE analyses of the isopeptide cleavage products. S, endogenous SUMO-modified RanGAP; C, cleaved RanGAP; GS, GST-SUMO-modified RanGAP. The identity of the GST-SUMO used in each reaction is shown on the right.
spatially removed from the active site and the extended substrate-binding region and thus probably do not contribute to differences in substrate specificity. The third region is defined by a variance in the relative orientations of helices G in XopD and Ulp1 (Figs. 5A and 6 ). This difference may be due to the requirement of an N-terminal truncation of XopD to obtain a stable protein sample for crystallization. In the Ulp1⅐Smt3 structure, helix G is tucked under helix A at the N terminus of the protein, and thus, the extra N-terminal residues may influence the packing of helix G in the structure. Several factors, including sequence divergence and the difference in construct length between the two proteins, may be responsible for the observed conformational variability of helices G. This helix is also spatially removed from the active site and extended substrate-binding region in XopD, but may play an as yet unknown role in substrate recognition.
To rule out significant structural changes in XopD upon mutation of the catalytic Cys 470 to Ala, the crystal structure of this mutant was determined. It is virtually identical to the structure of native XopD-(335-520) with a root mean square deviation of 0.31 Å for 168 common C-␣ atoms.
SUMO Mutational Studies-Although solving the structure of XopD did not directly provide information on the binding interactions between XopD and its SUMO substrates, the structure did allow for the creation of a structure-based sequence alignment of XopD with Ulp1. This structurebased sequence alignment provided the foundation for mutational studies to better understand how XopD recognizes its SUMO substrates. To further understand which portions of SUMO dictate XopD substrate recognition, mutational studies on T-SUMO and Smt3 were undertaken based on the SUMO sequence alignments (supplemental Fig. S1 ), activity assays ( Figs. 1 and 2) , and the newly derived structure-based sequence alignment of XopD and Ulp1 (Fig. 6) . XopD is able to process T-SUMO, AtSUMO-1, and AtSUMO-2 ( Figs. 1 and 3) , all of which contain the identical residues Met-Leu-His at the P 5 -P 7 positions. Substrates that XopD-(1-545) and XopD-(285-545) cannot process, such as yeast Smt3-HA, harbor different residues at the P 5 -P 7 positions (Fig. 3) . Interestingly, the residues at the P 5 and P 7 positions of Smt3 (Glu 94 and His92, respectively) were identified as contact residues in the structure of Ulp1⅐Smt3 (Fig. 7) (36) . To test the importance of the P 5 -P 7 residues for cleavage by XopD, this region of T-SUMO (MetLeu-His) was replaced with the corresponding region of Smt3 (His-Arg-Glu) and vice versa. XopD processed the P 5 -P 7 Smt3 mutant, albeit less efficiently (Fig. 8B) . Both XopD and Ulp1 processed less efficiently the reciprocal P 5 -P 7 T-SUMO mutant (Fig. 8J) . We conclude that the P 5 -P 7 region of 
, where the outer sum (h) is over the unique reflections and the inner sum (i) is over the set of independent observations of each unique reflection.
T-SUMO and Smt3 contributes to the substrate specificity of XopD. Because XopD inefficiently cleaved the P 5 -P 7 Smt3 mutant, we hypothesized that the interactions in the P 5 -P 7 region are insufficient and/or that additional residues contribute to substrate specificity. In the Ulp1⅐Smt3 structure, the side chain of (Figs. 6 and 7) . Thus, XopD⅐T-SUMO cannot have a hydrogen bond corresponding to the Smt3 Glu 94 -Ulp1 Asn 450 interaction. The lack of this hydrogen bond may be partly responsible for the inability of XopD to recognize and process Smt3. Further support of this hypothesis stems from a sequence alignment of XopD with eight proteases from plant bacterial pathogens (Bradyrhizobium japonicum, Mesorhizobium loti, and Pseudomonas syringae) that are members of the C48 family of cysteine proteases (2) . All of these proteases contain leucine or glycine at the position analogous to Leu 340 in XopD. By contrast, yeast Ulp1 and all SENPs contain asparagine at this position. Because Asn 450 in Ulp1 is conserved from yeast to man, the hydrogen bond between Asn 450 and Glu 94 (P 5 ) in Smt3 is likely important for coordinating substrate recognition. This hypothesis is consistent with our findings, revealing the importance of the P 5 site in XopD substrate recognition (Fig. 8, B and J) .
From a structure-based sequence alignment of XopD with the Ulp1⅐Smt3 complex, we ware able to identify other residues in SUMO that potentially contribute to the substrate specificity of XopD (Fig. 6) , but alignments of SUMOs show that the arginine at the P 35 position in Smt3 is replaced with alanine in T-SUMO, AtSUMO-1, and AtSUMO-2 (Figs. 3, 6, and 7) . Thus, the manner in which XopD recognizes its substrates at the P 35 position must be different because Ala cannot form an ionic interaction with Asp 341 in XopD. To test this hypothesis, we replaced the Smt3 arginine at the P 35 position with alanine and the T-SUMO alanine at the P 35 position with arginine. This P 35 Smt3 mutant could be partially processed by XopD (Fig. 8C) . When this mutation was combined with the P 5 -P 7 Smt3 mutant described above, the quadruple mutant (P 35 /P 5 -P 7 Smt3) was completely processed by full-length XopD (Fig. 8D) . Conversely, the P 35 /P 5 -P 7 T-SUMO quadruple mutant was less efficiently processed by XopD (Fig. 8L) . Thus, the residues at P 5 -P 7 and P 35 appear to be important specificity determinants.
Finally, analysis of the Ulp1⅐Smt3 structure revealed another residue (Ile 70 ) that may play a role in substrate specificity. This residue is located at the P 29 position in Smt3, which is a contact site between Smt3 and Ulp1 (36) . In T-SUMO, AtSUMO-1, and AtSUMO-2, arginine occupies the P 29 position. Mutation of the P 29 residue in Smt3 had little effect (by itself or in combination with the P 35 and/or P 5 -P 7 mutation) on the ability of XopD to process Smt3 (Fig. 8, E-H) . By contrast, mutation of the P 29 residue in T-SUMO to Ile (by itself or in combination with the P 35 and/or P 5 -P 7 mutation) completely abolished processing by XopD (Fig. 8, M-P) . Interestingly, the P 35 /P 29 /P 5 -P 7 Smt3 quintuple mutant was also an extremely poor substrate for Ulp1 (Fig. 8P) . These results support the hypothesis that residues other than those at the P 5 -P 7 positions and the neighboring P 35 (36) . Prior to solving the structure of XopD, we had hypothesized, based on sequence alignments of XopD with Ulp1, that Phe 366 could fulfill this role in XopD. Although Phe 474 is conserved in Ulp1 and all SENP family members, in XopD, glutamine is found at this position (2, 38) . Sequence alignments of XopD with other ULP family members from plant bacterial pathogens showed that none of them contains phenylalanine (or another hydrophobic amino acid) at this position (2) . The lack of this conserved Phe residue in XopD (and other plant bacterial ULP homologs) suggests that this site may play a role in ULP/SUMO recognition. Further sequence analysis revealed that the last SENP family member, SENP8, which removes Nedd8 modifications, also lacks this phenylalanine residue and that it instead has a glutamine residue at this position (2) . Sequence analysis of two deubiquitinating enzymes that were recently characterized from Chlamydia trachomatis showed that, in place of the conserved phenylalanine from Ulp1 and SENP family members, there is also a glutamine residue at this position (2, 39) . The finding that deubiquitinating enzymes and deneddylating enzymes lack the phenylalanine residue of Ulp1 and SENPs further supports the notion that this phenylalanine residue may play a role in Smt3 and M-SUMO recognition. Future studies on the phenylalanine and surrounding residues may provide further insight into the importance of this region of contact between the substrate and enzyme.
XopD exhibits rigid SUMO substrate specificity whereby it will process only certain plant SUMOs, i.e. T-SUMO, AtSUMO-1, and AtSUMO-2 (Fig. 1) . Yeast Ulp1 acts as a more The numbering is shown with respect to XopD. The XopD secondary structure is shown above the sequence in purple, and the yeast Ulp1 secondary structure is shown below the sequence in green. ␤-Strands (arrows) are numbered, and helices (boxes) are lettered. Dotted lines represent residues missing from the XopD structure. Catalytic residues are shown in blue. FIGURE 7. Close-up view of catalytic residues and contact residues. Contact residues identified in the Ulp1⅐Smt3 structure are labeled to show where mutations were made in Smt3 (36) . Yeast Ulp1 is shown in green and is in complex with Smt3 (blue). The yellow portion of Smt3 represents the C-terminal QIGG residues that contact Ulp1. Residues in Ulp1 and Smt3 are labeled, and the corresponding residues in XopD and T-SUMO are in parentheses.
promiscuous desumoylating enzyme compared with XopD because yeast Ulp1 will process a variety of SUMO substrates (Fig. 1) . The information gained from peptidase assays and SUMO sequence alignments led to our proposal that the residues at the P 35 , P 29 , and P 5 -P 7 positions of SUMO contribute to the substrate specificity of XopD (Figs. 1, 3, and 8) . By solving and analyzing the crystal structure of XopD and by combining these studies with further enzymatic and bioinformatic analyses, we discovered residues and secondary structures that are important for the specificity of various members of the ULP family of enzymes. Future studies on the role of the N-terminal domain of XopD (or any ULP family member) and the actual SUMO-modified targets in plants as well as the XopD⅐T-SUMO complex structure will provide further understanding of the enzymatic activity and specificity of the ULP family of proteases.
